1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Drug Discovery Awards is sponsored by The Mark Foundation for Cancer Research. This program supports academic scientists in advancing high-potential targets for cancer therapeutics with industry-level rigor. It provides resources and expertise to support post-target validation through early lead development.
While focused on cancer, drug discovery methodologies, including those utilizing AI, are relevant.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Drug Discovery Award | The Mark Foundation for Cancer Research The Mark Foundation for Cancer Research The Mark Foundation for Cancer Research The Mark Foundation for Cancer Research is dedicated to accelerating exciting academic discoveries into new therapies and platforms that will substantially improve outcomes for cancer patients.
Currently, there are few options for academic scientists to obtain the resources and know-how to advance drug discovery efforts for promising new cancer targets. To stem this gap, The Mark Foundation has established the Drug Discovery Award program.
Through this program, The Mark Foundation aligns with investigators working to discover and progress a new therapeutic agent into preclinical development, providing not only resources to support post-target validation through early lead development but also the expertise of seasoned biopharma R&D scientists who will advise on activities on the critical path to developing a new therapeutic agent.
In March 2026, The Mark Foundation awarded four new Drug Discovery Awards. Learn more about their work: 2026 Drug Discovery Awards
According to the current listing, eligibility includes: Academic research teams focused on novel anticancer therapeutics from post-target validation through early lead development. Confirm the full requirements in the official notice before applying.
The current listing shows $4,000,000 total in 2026 cycle (individual amounts not specified). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Drug Discovery Awards is funded by The Mark Foundation for Cancer Research. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article